“The world's speediest news portal”
One News Page
> >

Naia Rare Diseases Announces Clinical Trial Authorisation (CTA) to Initiate Clinical Trials of NB 1001 for Short Bowel Syndrome in the United Kingdom

Marketwired Wednesday, 15 November 2017
RICHMOND, CA--(Marketwired - November 15, 2017) - Naia Rare Diseases, a biopharmaceutical company developing drugs for Short Bowel Syndrome (SBS) and other rare gastrointestinal diseases today announced that it has received Clinical Trial Authorisation ("CTA") from the Medicine and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom to initiate a clinical trial of its long-acting GLP-1 agonist, NB 1001, in adult patients with SBS.
Share on
Share on
Post on 
Share by

You Might Like

Recent related news

Bionomics begins phase II clinical trial of drug for treating agitation

Bionomics Ltd (ASX:BNO) has commenced a phase II clinical trial of its therapeutic candidate, BNC210, in elderly patients with agitation in the hospital setting....
Proactive Investors - BusinessAlso reported by •GlobeNewswireBusiness Wire

Oppenheimer looks beyond ‘wall of worry’ in US biotech sector’s anemic 1Q sales toward a 'seasonally better' 2Q

Analysts at Oppenheimer weighed in on the US biotechnology sector Tuesday, saying that they have a “wall of worry” about pressure on drug prices and anemic...
Proactive Investors - Business

Clovis Oncology Announces Presentations at 2018 ASCO Annual Meeting

Clovis Oncology Announces Presentations at 2018 ASCO Annual Meeting
BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that seven abstracts highlighting progress in the Rubraca preclinical...
Business Wire - Press ReleasesAlso reported by •GlobeNewswire

Loxo Oncology shares soar on rosy data from Phase 1 cancer drug trial

Shares of Loxo Oncology Inc. (NASDAQ: LOXO), a biopharmaceutical company, soared Thursday after the cancer specialist revealed that its drug LOXO-292 shrunk...
Proactive Investors - Business

G1 Therapeutics to Present Phase 1b Data on G1T38 in Combination with Faslodex for Treatment of Breast Cancer at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

RESEARCH TRIANGLE PARK, N.C., May 16, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq:GTHX), a clinical-stage oncology company, today announced that...
GlobeNewswire - Press ReleasesAlso reported by •Business Wire

Tweets about this

Other recent news in Press Releases

Landos Biopharma to Participate in Upcoming Digestive Disease Week Conference and BIO INTERNATIONAL ConventionTL Plastic Surgery attended the International SYMPOSIUM of Korean Society of Aesthetic Plastic Surgery and Korean Association of Plastic Surgeons, APS 2018
Leaf Group TO PARTICIPATE at the Cowen and Company 46th Annual Technology, Media & Telecom ConferenceNEW YORK University Scientists Trace Cybercrime Banking Networks and Win Best Research Paper Award
eRace Cancer Says 15-Year Cancer Survivor Don Wright – Still on Active Treatment – Enters His First Qualifying Race for the National Senior Games, June 2nd, in LOS ANGELESNew ENGLAND College of Business Pays It Forward with Tuition Discount and Prior Learning Credits for First Responders, Law Enforcement and Active Military

Recent related videos

News video: 5 Signs That May Show You're Not As Healthy As You Think

▶ 5 Signs That May Show You're Not As Healthy As You Think 00:36

Although one may think they are healthy there are some signs that indicate that you are not. 1. Snoring has been linked to health conditions like sleep apnea, excess weight and heart disease. 2...
Source: Wochit News -

News video: Rare Rhino Born in U.K. after 16 Months in Womb

▶ Rare Rhino Born in U.K. after 16 Months in Womb 01:08

A rare greater one-horned rhino just had a baby and he's adorable! His mom, Asha, carried him for 16 months, but she was only in labor for about 20 minutes. Her new baby may be cute, but his arrival is..
Source: InsideEdition -

News video: Is There Any Actual Science Behind Stem Cell Therapy?

▶ Is There Any Actual Science Behind Stem Cell Therapy? 04:11

In 2017, three women went blind after paying a so-called ‘stem cell clinic’ in Florida thousands of dollars to treat their macular degeneration. Why are these stem cell therapies dangerous, and why..
Source: Seeker -

News video: Local Angler Finds Rare Salamander in the Kiski River

▶ Local Angler Finds Rare Salamander in the Kiski River 01:35

Video captured by Pennsylvania resident Larry Dones shows a rare Hellbender salamander he hooked while fishing for crawfish on the Kiski River in Tributary on April 30.In a post to Facebook, Dones..
Source: Storyful Studio -

News video: BOE Could Delay Rate Hike Until August

▶ BOE Could Delay Rate Hike Until August 01:59

Apr.27 -- The British economy's first-quarter growth fell short of analyst estimates and could mean a delay in rate hikes for the Bank of England. Bloomberg Economics' Dan Hanson reports on "Bloomberg..
Source: Bloomberg Politics -

News video: Keeping livers 'alive' improves transplant success

▶ Keeping livers 'alive' improves transplant success 01:01

OXFORD, UNITED KINGDOM — Preserving livers in warm storage similar to body temperature rather than cold storage improves transplant success a clinical trial has found. Transplant livers are..
Source: TomoNews US -

News video: Top 10 Animals You’ve Never Heard Of

▶ Top 10 Animals You’ve Never Heard Of 07:00

The animal kingdom is larger than most people realize. From the Snub-Nosed Monkey, to the Lowland Streaked Tenrec, to the Gharial, these mysterious little creatures might be flying under your radar...
Source: WatchMojo - Affiliate -

News video: ISIS Fighters Known As 'The Beatles' Want Fair Trial

▶ ISIS Fighters Known As 'The Beatles' Want Fair Trial 00:52

Two of the most wanted fighters from the British ISIS cell called "the Beatles" have called some of the group's actions "regrettable," and insisted that their legal rights are respected wherever..
Source: Wochit News -

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2018 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+